[1]
V. R. Munawarah, F. P. Gurning, and Z. Aidha, “Cost of Illness Analysis and the Impact of JKN Utilization on Patients with Type 2 Diabetes Mellitus”, IJGHR, vol. 6, no. 3, pp. 1727-1736, May 2024.